Galien Foundation Announces Final Program for 3rd Annual Galien Forum on October 16

   Galien Foundation Announces Final Program for 3rd Annual Galien Forum on
                                  October 16

Program Includes Biopharmaceutical and Health Policy Luminaries FDA
Commissioner Margaret Hamburg, M.D.; Prof. Guido Rasi, Executive Director,
European Medicines Agency; P. Roy Vagelos, M.D.; Fred Hassan and others;
Special Appearance By Nobel Peace Prize Laureate Elie Wiesel

PR Newswire

NEW YORK, Oct. 12, 2012

NEW YORK, Oct. 12, 2012 /PRNewswire/ -- The Galien Foundation Board announced
today the final program for the 3^rd Annual Galien Forum to be held in New
York City at the Alexandria Center™ for Life Science on Tuesday, October 16
from 8AM to 4PM.

(Logo: http://photos.prnewswire.com/prnh/20120416/NY87735LOGO)

"Health decision executives from the world's leading regulatory bodies,
biopharmaceutical and service companies will be on hand to discuss, debate and
advance some of the world's pressing health concerns at the Galien Forum,"
notes Bruno Cohen, chairman of the Galien Foundation and secretary general of
the Prix Galien Award Program. "We are encouraged that the heads of the U.S.
Food and Drug Administration and the European Medicines Agency – together
responsible for overseeing regulatory affairs for drug innovation for more
than two-thirds of the global medicines market – as well as leaders of the
world's leading biopharma innovation companies consider the Forum an
opportunity to share viewpoints and discuss emerging policies."

This year's program includes:

  oIntroductory Remarks by P. Roy Vagelos, M.D., Chairman of the Prix Galien
    USA Committee, Chairman of Regeneron and retired Chairman and CEO of Merck
  oA Panel on the Future of Biophamaceuticals Innovation with Dr. Vagelos and
    Fred Hassan, Chairman of Bausch + Lomb and former Chairman and CEO of
    Schering-Plough
  oPolicy panels with Margaret Hamburg, M.D., Food and Drug Administration
    (FDA) Commissioner and Prof. Guido Rasi, Executive Director, European
    Medicines Agency
  oA Plenary Presentation on the Ethics of Innovation by Professor Elie
    Wiesel, Author and Nobel Peace Prize Laureate
  oAlzheimer's disease researchers and advocates from FDA, National
    Institutes of Health, Alzheimer's Association and Geoffrey Beene
    Foundation will discuss the White House 2025 treatment initiative in an
    expert panel moderated by Michael Rosenblatt, M.D., Chief Medical Officer
    of Merck
  oExperts from the Mayo Clinic, Harvard and Pfizer will explore
    possibilities resulting from combining genomics in personalized medicine
    on a panel moderated by Kris Joshi, Ph.D., Global Vice President, Oracle
    Health Sciences
  oMaria Freire, Ph.D., President, Albert and Mary Lasker Foundation, will
    lead a panel on "Infectious Diseases: A Global Health Challenge," with
    leaders from the Institut Pasteur, FDA, Glaxo and Merck
  oThe opportunities of the high-growth, emerging market of China will be
    debated by top thinkers from Stravencon, Palliwag, Deloitte LLP,
    Foundation Medical Development, Ferghana Partners and Aisling Capital.

The full program and instructions for registration can be found at:
http://www.galienfoundation.org/the-galien-forum/program.php.

About the Galien Foundation and the Prix Galien Awards
The mission of the Galien Foundation is to serve as a vehicle for the open
exchange of ideas that drive science and new innovations. The Foundation's
third major forum will be held at the Alexandria Center for Life Science on
the morning of October 16, 2012, and will feature round table discussions
focusing on critical, global healthcare issues and challenges.

The Prix Galien Awards were created to honor medical research and pharmacology
for outstanding efforts to improve the human condition though approval of
innovative treatments and medicines. The winners are selected by a preeminent
scientific and learned committee that included several Nobel Laureates. Past
product award recipients include; Prevnar 13^® (Pfizer 2011), Stelara^®
(Janssen 2011), Prolia^®/XGEVA^® (Amgen 2011), Coartem^® (Novartis 2010),
RotaTeq^® (Merck 2010), xTAG^® (Luminex 2010), Gleevec^® (Novartis 2009),
Nplate^® (Amgen 2009), Promacta^® (GSK 2009), Cellsearch^® (Veridex 2009),
Isentress^® (Merck 2009), Selzentry^® (Pfizer 2008), Soliris^® (Alexion 2008),
Infuse^® (Wyeth 2008), Revlimid^® (Celgene 2008), Januvia^® (Merck 2007),
Chantix^® (Pfizer 2007), Humira^® (Abbott 2007) and Gardasil^® (Merck 2007).

The Pro Bono Humanum Award recognizes exemplary efforts by individuals and
organizations in helping mankind. The award will be presented by Professor
Elie Wiesel, a Nobel Prize Laureate. Previous winners of the award include:
Professor Paul Farmer (2011); President Bill Clinton and Philippe Douste-Blazy
(2010); Professors Barry Bloom and Jeffrey Sachs (2009); Sheldon Segal and the
Population Council (2008); and Dr. P. Roy Vagelos (2007).

For more information about the Prix Galien USA award and committee, visit
www.galienfoundation.org.





SOURCE Galien Foundation

Website: http://www.galienfoundation.org
Contact: Lee A. Davies, Makovsky Integrated Communications for Prix Galien
USA, +1-212-508-9651